An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017

被引：123

作者：

Sinclair A.J. ^{[1
]}

Abdelhafiz A. ^{[2
]}

Dunning T. ^{[3
]}

Izquierdo M. ^{[4
]}

Rodriguez Manas L. ^{[5
]}

Bourdel-Marchasson I. ^{[6
,11
]}

Morley J.E. ^{[7
]}

Munshi M. ^{[8
]}

Woo J. ^{[9
]}

Vellas B. ^{[10
]}

机构：

[1] Foundation for Diabetes Research in Older People, Diabetes Frail Ltd and University of Aston, Birmingham

[2] Rotherham General Hospital, Rotherham

[3] Deakin University, Geelong

[4] Public University of Navarre, Pamplona

[5] Universitario Hospital de Getafe, Getafe

[6] CHU Bordeaux, Bordeaux

[7] St Louis University, WA

[8] Harvard University, Cambridge

[9] Gerontopole and Hopitaux de Toulouse, Toulouse

[10] UMR 5536 Univ Bordeaux/CNRS, Bordeaux

来源：

The Journal of Frailty & Aging | 2018年 / 7卷 / 1期

关键词：

Diabetes mellitus; frailty; management; older people; position statement; sarcopenia;

D O I：

10.14283/jfa.2017.39

中图分类号：

学科分类号：

摘要：

Aim: the the International Position Statement provides the opportunity to summarise all existing clinical trial and best practice evidence for older people with frailty and diabetes. It is the first document of its kind and is intended to support clinical decisions that will enhance safety in management and promote high quality care. Methods: the Review Group sought evidence from a wide range of studies that provide sufficient confidence (in the absence of grading) for the basis of each recommendation. This was supported by a given rationale and key references for our recommendations in each section, all of which have been reviewed by leading international experts. Searches for any relevant clinical evidence were generally limited to English language citations over the previous 15 years. The following databases were examined: Embase, Medline/PubMed, Cochrane Trials Register, Cinahl, and Science Citation. Hand searching of 16 key major peer-reviewed journals was undertaken by two reviewers (AJS and AA) and these included Lancet, Diabetes, Diabetologia, Diabetes Care, British Medical Journal, New England Journal of Medicine, Journal of the American Medical Association, Journal of Frailty & Aging, Journal of the American Medical Directors Association, and Journals of Gerontology - Series A Biological Sciences and Medical Sciences. Results: two scientific supporting statements have been provided that relate to the area of frailty and diabetes; this is accompanied by evidence-based decisions in 9 clinical domains. The Summary has been supported by diagrammatic figures and a table relating to the inter-relations between frailty and diabetes, a frailty assessment pathway, an exercise-based programme of intervention, a glucose-lowering algorithm with a description of available therapies. Conclusions: we have provided an up to date evidence-based approach to practical decision-making for older adults with frailty and diabetes. This Summary document includes a user-friendly set of recommendations that should be considered for implementation in primary, community-based and secondary care settings. © 2018, Serdi and Springer-Verlag France SAS, part of Springer Nature.

引用

页码：10 / 20

页数：10

共 36 条

[1]

Sinclair A.J., Dunning T., Rodriguez-Manas L., Diabetes mellitus in older people, New insights and residual challenges. Lancet Diabetes Endocrinol, 3, (2015)

[2]

Kirkman M.S., Briscoe V.J., Clark N., Florez H., Haas L.B., Halter J.B., Et al., Diabetes in older adults, Diabetes Care., 35, 12, pp. 2650-2664, (2012)

[3]

Weiss C.O., Frailty and chronic diseases in older adults, Clin Geriatr Med., 27, 1, pp. 39-52, (2011)

[4]

Lubitz J., Cai L., Kramarow E., Lentzner H., Health, life expectancy, and health care spending among the elderly, N Engl^J Med., 349, 11, pp. 1048-1055, (2003)

[5]

Sinclair A.J., Abdelhafiz A.H., Rodriguez-Manas L., Frailty and sarcopenia–newly emerging and high impact complications of diabetes, J Diabetes Complications, (2017)

[6]

Morley J.E., Malmstrom T.K., Rodriguez-Manas L., Sinclair A.J., Frailty, sarcopenia and diabetes, J Am Med Dir Assoc., 15, pp. 853-859, (2014)

[7]

Castro-Rodriguez M., Carnicero J.A., Garcia-Garcia F.J., Walter S., Morley J.E., Rodriguez-Artalejo F., Sinclair A.J., Rodriguez-Manas L., Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes, J Am Med Dir Assoc, pp. 949-955, (2016)

[8]

Sinclair A.J., Paolisso G., Castro M., Bourdel-Marchasson I., Gadsby R., Rodriguez Manas L., European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary–A Report of the European Diabetes Working Party for Older People (EDWPOP) Revision Group on Clinical Practice Guidelines for Type 2 Diabetes Mellitus, Diabetes Metab, 37, pp. S27-S38, (2011)

[9]

Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., Et al., Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care., 38, 1, pp. 140-149, (2015)

[10]

Sinclair A., Vellas B., Frailty–an emerging high impact complication of diabetes requiring specific management approaches, JNHA, 21, 2, pp. 193-194, (2017)

← 1 2 3 4 →